BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

Overview Fund Activity

21 hedge funds and large institutions have $6.5M invested in ProShares Ultra NASDAQ Biotechnology in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
-3
Holders Change %
-12.5%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
5
Closed
5
Calls
$752K
Puts
$465K
Net Calls
+$287K
Net Calls Change
+$495K

Top Buyers

1
IMC Chicago
IMC Chicago
Illinois
$1.46M
2
WWM
Westwood Wealth Management
California
$893K
3
Jane Street
Jane Street
New York
$306K
4
TC
Truvestments Capital
Florida
$7.97K
5
Morgan Stanley
Morgan Stanley
New York
$51.5K

Top Sellers

1
TRCT
Tower Research Capital (TRC)
New York
$259K
2
Citadel Advisors
Citadel Advisors
Florida
$121K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$800K
4
CIC
Chase Investment Counsel
Virginia
$572K
5
TFA
Toth Financial Advisory
Virginia
$730K
Name Holding Trade Value Shares
Change 		Shares
Change %
ATPW
26
Ashton Thomas Private Wealth
Arizona
– -$7.65K -129 Closed
1
2